S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26

Stratec (SBS) Stock Forecast, Price & News

-0.20 (-0.20%)
(As of 05/25/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
2,745 shs
Average Volume
6,253 shs
Market Capitalization
$1.20 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

Stratec logo

About Stratec

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.


See More Headlines

Industry, Sector and Symbol

Medical Devices
Year Founded

Sales & Book Value

Annual Sales
$290.73 million
Cash Flow
€4.11 per share
Book Value
€17.94 per share


Pretax Margin




Free Float
Market Cap
$1.20 billion

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.45 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Stratec (ETR:SBS) Frequently Asked Questions

When is Stratec's next earnings date?

Stratec is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Stratec

Is Stratec a good dividend stock?

Stratec pays an annual dividend of €0.95 per share and currently has a dividend yield of 0.94%. The dividend payout ratio of Stratec is 29.23%. This payout ratio is at a healthy, sustainable level, below 75%.

What price target have analysts set for SBS?

0 analysts have issued 12 month price objectives for Stratec's shares. Their forecasts range from €116.00 to €154.00. On average, they anticipate Stratec's share price to reach €134.40 in the next twelve months. This suggests a possible upside of 35.8% from the stock's current price.
View analysts' price targets for Stratec
or view top-rated stocks among Wall Street analysts.

Who are Stratec's key executives?
Stratec's management team includes the following people:
  • Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 55, Pay $707k)
  • Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 55, Pay $566k)
  • Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 55, Pay $484k)
  • Mr. Hermann Leistner, Founder & Advisor (Age 76)
  • Mr. Jan Keppeler, Head of Investor Relations & Corp. Communications
  • Mr. Andre Loy, Director of Corp. Communications
  • Mr. Roland Utz, Head of Supply Chain Management & Sr. VP
What other stocks do shareholders of Stratec own?
What is Stratec's stock symbol?

Stratec trades on the ETR under the ticker symbol "SBS."

What is Stratec's stock price today?

One share of SBS stock can currently be purchased for approximately €99.00.

How much money does Stratec make?

Stratec has a market capitalization of $1.20 billion and generates $290.73 million in revenue each year.

How many employees does Stratec have?

Stratec employs 1,282 workers across the globe.

What is Stratec's official website?

The official website for Stratec is www.stratec.com.

How can I contact Stratec?

Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.

This page was last updated on 5/26/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.